| Year |
Citation |
Score |
| 2021 |
Ma Y, Dammer EB, Felsky D, Duong DM, Klein HU, White CC, Zhou M, Logsdon BA, McCabe C, Xu J, Wang M, Wingo TS, Lah JJ, Zhang B, Schneider J, et al. Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue. Nature Communications. 12: 7035. PMID 34857756 DOI: 10.1038/s41467-021-27204-9 |
0.72 |
|
| 2021 |
Guo Q, Dammer EB, Zhou M, Kundinger SR, Gearing M, Lah JJ, Levey AI, Shulman JM, Seyfried NT. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease. Frontiers in Molecular Neuroscience. 14: 623659. PMID 33815056 DOI: 10.3389/fnmol.2021.623659 |
0.643 |
|
| 2021 |
Xu MM, Zhou MT, Li SW, Zhen XC, Yang S. Glycoproteins as diagnostic and prognostic biomarkers for neurodegenerative diseases: A glycoproteomic approach. Journal of Neuroscience Research. PMID 33634546 DOI: 10.1002/jnr.24805 |
0.438 |
|
| 2020 |
Higginbotham L, Ping L, Dammer EB, Duong DM, Zhou M, Gearing M, Hurst C, Glass JD, Factor SA, Johnson ECB, Hajjar I, Lah JJ, Levey AI, Seyfried NT. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer's disease. Science Advances. 6. PMID 33087358 DOI: 10.1126/sciadv.aaz9360 |
0.671 |
|
| 2020 |
Zhou M, Haque RU, Dammer EB, Duong DM, Ping L, Johnson ECB, Lah JJ, Levey AI, Seyfried NT. Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer's disease. Clinical Proteomics. 17: 19. PMID 32514259 DOI: 10.1186/S12014-020-09285-8 |
0.769 |
|
| 2020 |
Johnson ECB, Dammer EB, Duong DM, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, et al. Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation. Nature Medicine. PMID 32284590 DOI: 10.1038/S41591-020-0815-6 |
0.77 |
|
| 2020 |
Higginbotham LA, Ping L, Dammer EB, Duong D, Zhou M, Gearing M, Johnson EC, Hajjar I, Lah JJ, Levey AI, Seyfried NT. Proteomics identifies CSF biomarker panels reflective of pathological networks in the Alzheimer's disease brain Alzheimer's & Dementia. 16. DOI: 10.1002/alz.042227 |
0.539 |
|
| 2020 |
Johnson EC, Dammer EB, Duong D, Ping L, Zhou M, Yin L, Higginbotham LA, Guajardo A, White B, Troncoso JC, Thambisetty M, Montine TJ, Lee EB, Trojanowski JQ, Beach TG, et al. A consensus proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039504 |
0.366 |
|
| 2019 |
Zhou M, Duong DM, Johnson ECB, Dai J, Lah JJ, Levey AI, Seyfried NT. Mass spectrometry-based quantification of Tau in human cerebrospinal fluid using a complementary tryptic peptide standard. Journal of Proteome Research. PMID 30983353 DOI: 10.1021/Acs.Jproteome.8B00920 |
0.589 |
|
| 2019 |
Ping L, Higginbotham LA, Dammer EB, Duong D, Zhou M, Wingo TS, Johnson EC, Lah JJ, Levey AI, Seyfried NT. INTEGRATIVE PROTEOMICS LINKS CEREBROSPINAL FLUID BIOMARKERS TO PATHOLOGICAL NETWORKS IN THE ALZHEIMER’S DISEASE BRAIN Alzheimer's & Dementia. 15: P191. DOI: 10.1016/J.Jalz.2019.06.4517 |
0.708 |
|
| 2017 |
Wingo TS, Duong DM, Zhou M, Dammer EB, Wu H, Cutler DJ, Lah JJ, Levey AI, Seyfried NT. Integrating Next-Generation Genomic Sequencing and Mass Spectrometry to Estimate Allele-Specific Protein Abundance in Human Brain. Journal of Proteome Research. PMID 28691493 DOI: 10.1021/Acs.Jproteome.7B00324 |
0.668 |
|
| Show low-probability matches. |